Intrathecal Drug Delivery (IDD)

Chronic pain is a largely under-treated and misunderstood disease that affects millions of people worldwide. It is defined as moderate to severe pain that persists longer than would generally be expected for recovery to a specific disease, injury or surgery. According to the National Institutes of Health, 90 million people in the U.S. suffer from chronic pain. The American Pain Foundation estimates that chronic pain costs approximately $100 billion per year in lost work time and health care expenses.

Intrathecal drug delivery (IDD) is a proven option for pain patients that have not responded well to oral pain medications or are not good candidates for SCS.

These implantable devices send pain medication directly to the fluid around the spinal cord, providing pain relief with a small fraction of the medication needed if taken orally.

To join us in our efforts, click on Advocacy Center and sign up to become an advocate for neuromodulation.